Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study. (2019)
Attributed to:
University of Edinburgh Momentum Award – Dementias
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(18)30391-0
PubMed Identifier: 30563778
Publication URI: http://europepmc.org/abstract/MED/30563778
Type: Journal Article/Review
Volume: 18
Parent Publication: The Lancet. Neurology
Issue: 2
ISSN: 1474-4422